Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Allison Beck"'
Autor:
Lilin Lai, Allison Beck, Gitika Panicker, Aya Nakamura, Colleen F. Kelley, Briyana Domjahn, Andrew Cheng, Srilatha Edupuganti, Kevin A. Ault, Mirjana Nesin, Nadine Rouphael, Elizabeth R. Unger, Yongxian Xu, Rebecca Hoagland, Mark J. Mulligan, Karen Mask, Hagit David, Evan J. Anderson
Publikováno v:
Vaccines
Volume 8
Issue 3
Vaccines, Vol 8, Iss 348, p 348 (2020)
Volume 8
Issue 3
Vaccines, Vol 8, Iss 348, p 348 (2020)
Human papillomavirus virus (HPV) vaccines aim to provide durable protection and are ideal to study the association of cellular with humoral responses. We assessed the duration and characteristics of immune responses provided by the quadrivalent HPV (
Autor:
Hana M. El Sahly, Mark J. Mulligan, Sharon E. Frey, Shital M. Patel, Marcelo B. Sztein, Robert L. Atmar, Irene Graham, Srilatha Edupuganti, Edwin L. Anderson, Allison Beck, Heather Hill, Patricia L. Winokur, Nadine Rouphael, Jack T. Stapleton, Johannes B. Goll, Samer S. El-Kamary, Marcela F. Pasetti, Wendy A. Keitel, Wilbur H. Chen
Publikováno v:
Vaccine. 35:4730-4737
Background Tularemia is caused by Francisella tularensis , a gram-negative bacterium that has been weaponized as an aerosol. For protection of personnel conducting biodefense research, the United States Army required clinical evaluation of a new lot
Autor:
Tara N. Palmore, Mark Wolcott, Colleen S. Kraft, Aneesh K. Mehta, Anthony F. Suffredini, Timothy M. Uyeki, William Dorman, Allison Beck, Mark J. Mulligan, Karen K. Wong, Christopher J. Kratochvil, Philip W. Smith, Ute Ströher, Richard T. Davey, Lilin Lai, Angela L. Hewlett, Susan Rogers
Publikováno v:
Clinical Infectious Diseases. 63:376-379
From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients
Autor:
Clemente Diaz, Michelle Conan-Cibotti, Josephine H. Cox, Kimberly A. Dowd, Florence Kaltovich, John R. Mascola, Ingelise J. Gordon, Rebecca Lampley, Robert T. Bailer, Brittanie Brockett, Barney S. Graham, Doug Haney, Jeanine May, David Gordon, Kevin Carlton, Theodore C. Pierson, Nicolas Rosario, Yeycy Donastorg, Nina M. Berkowitz, Jason G. D. Gall, Richard A. Koup, André Cabié, Jason Mendy, Brenda Larkin, Sarah H. Plummer, Cristina Carter, Allison Beck, Jean W. Pape, Mark O’Callahan, Bruno Hoen, Charla A. Andrews, Amy Bray, Grace L. Chen, Julie E. Ledgerwood, Richard M. Schwartz, Emily E. Coates
Publikováno v:
JAMA. 323:1369
Importance Chikungunya virus (CHIKV) is a mosquito-borneAlphavirusprevalent worldwide. There are currently no licensed vaccines or therapies. Objective To evaluate the safety and tolerability of an investigational CHIKV virus–like particle (VLP) va
Autor:
Allison Beck, Steve Johnson, Michael Schultz, Margaret Fraser, Barbara Smith, Kristina Aluzaite, Jack Dummer, Jordan Tewhaiti-Smith, Elizabeth Glen
Publikováno v:
Royal Society Open Science, Vol 5, Iss 8 (2018)
Hepatitis C virus (HCV) and B virus (HBV) infections are highly prevalent, with a high percentage of undiagnosed cases. Knowledge of HCV and its modes of transmission are essential for disease prevention and management. We studied a high-risk New Zea
Autor:
Patrick Rago, Muktha S Natrajan, Yongxian Xu, Srilatha Edupuganti, Jessica K. Fairley, Shital M. Patel, Yi-Juan Hu, Nicole Kasher, Charles E. Hill, Emory Zika Patient Study Team, Nadine Rouphael, Henry M. Wu, Kristy O. Murray, Lilin Lai, Mari Hart, Matthew Feldhammer, Allison Beck, Amanda Feldpausch, Mark J. Mulligan, Pamela Lankford-Turner
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Understanding the immune response during acute Zika in humans will aid vaccine design and testing. In 5 acute patients, including 2 pregnant women, viral levels and innate, T-, and B-cell responses against Zika or dengue viruses are described.
B
B